Acne 

Actinic Keratosis 

Aesthetics

Alopecia

Biologic Treatments for Moderate to Severe Atopic Dermatitis 

Atopic Dermatitis 

COVID-19

Chronic Hand Eczema

Drug Watch

Eczema

General Dermatology 

Hidradenitis Suppurativa

Melasma

NP and PA

Pediatric Dermatology

Pigmentary Disorders 

Practice Management 

Precision Medicine and Biologics

Prurigo Nodularis

Emerging Therapies Plaque Psoriasis

Treatments for Plaque Psoriasis 

Psoriasis 

Psoriatic Arthritis 

Rare Disease

Rosacea 

Skin Cancer (Nonmelanoma)

Skin Cancer

Vitiligo

Wound Care

News

Media

Around the Practice

Between The Lines

Case-Based Peer Perspective

Clinical Case Collective

DermView

Expert Perspectives

Fellows Face Off

Frontline Forum

Medical World News

Patient Perspectives

Podcasts

Readout360

Recognize and Refer

Conferences

Conference Coverage

Conference Listing

Events

Case-Based Roundtable

Publication

Dermatology Times

CME/CE

Resources

DermIQ

Interactive Tools

Job Board

Partner Perspectives

Perspectives in Dermatology

Polls

Editorial Advisory Board

Partners

Subscribe

Marie Bosslett is the assistant editor of 

 and joined the MJH Life Sciences team in October 2024. She attended Loyola University Maryland in Baltimore and earned a Bachelor of Arts in Communication with minors in marketing and writing. When she’s not writing, Marie enjoys going to concerts, reading on the beach, and spending time with friends and family.

Articles

Australian researchers found 5-FU to be the cheapest AK treatment, compared to imiquimod and MAL-photodynamic therapy.

5-Fluorouracil is the Most Cost-Effective Therapy for Actinic Keratosis

A novel study assessed the potential of 2 AI platforms in providing accurate information to patients with HS.

AI Chatbots Can Provide Support to Patients with Hidradenitis Suppurativa

Maddi Hebebrand is an associate editor of 

and joined the MJH Life Sciences team in May 2024. She attended Baldwin Wallace University, studying Media Production and Film, and is now finishing her Masters in Digital Media through Ohio University. When she's not writing, Maddi loves to read, attend concerts and spend time with her family.

Research suggested acne is primarily inflammatory, occurring even in unaffected skin, redefining its pathophysiology.

Study Reveals 90% Acne Severity Reduction with TF-LDM

and joined the MJH Life Sciences team in February 2023. She attended Kent State University and earned a Bachelor of Science degree in journalism with minors in public relations and creative writing. She enjoys making and listening to music, reading, and spending time with her cats, Astrid and Marceline.

ENS-002 targets S. aureus in atopic dermatitis.

Concerto Biosciences Doses First Participant in Phase 1 Trial of ENS-002, a Microbiome-Based Therapy for Atopic Dermatitis

About

Advertise

Contact Us

Do Not Sell My Information

Terms and Conditions

Privacy Policy

Dermatology Times and Multimedia Medical, LLC

Facebook

Linkedin

Topics

Acne

Pigmentary Disorders

Practice Management

Psoriasis

Psoriatic Arthritis

Rosacea

Strategic Alliance Partnership

1rem

Strategic Alliance Partners

The Hidradenitis Suppurativa Foundation offers grants for HS research and clinical expertise, supporting early-stage to established investigators.

Grant Opportunities from the Hidradenitis Suppurativa Foundation: Supporting Innovation and Expertise in HS Research and Care

Hadar Lev-Tov, MD, MAS, President of the HS Foundation, discusses the organization's hopes for the future and upcoming efforts.

'All Hands on Deck' for Hidradenitis Suppurativa: HS Foundation Spotlights Advocacy, Education Initiatives

Mission: To improve the lives of people affected by HS through advocacy, education, and research.

Vision: A world where no one suffers from HS.

HS Foundation

HS Foundation | Strategic Alliance Partners

Latest from HS Foundation